RNF7 (Ring Finger Protein 7), also known as COP9 signalosome subunit 3 (CSN3), is a key component of the COP9 signalosome complex, which regulates cellular processes like protein degradation, DNA repair, and cell cycle control. This ubiquitously expressed protein contains a conserved RING finger domain, enabling its role in ubiquitination—a post-translational modification critical for protein stability, localization, and interactions. RNF7 interacts with cullin proteins to modulate the activity of cullin-RING ubiquitin ligases (CRLs), influencing pathways such as apoptosis, stress response, and tumorigenesis.
Antibodies targeting RNF7 are essential tools for studying its expression, function, and regulatory mechanisms. They are widely used in techniques like Western blotting, immunohistochemistry, and immunoprecipitation to explore RNF7's involvement in diseases. Research links RNF7 dysregulation to cancers (e.g., breast, lung) due to its role in promoting oncoprotein stability or degrading tumor suppressors. It is also implicated in neurodegenerative disorders and immune responses. Additionally, studies highlight its interaction with viral proteins, suggesting a role in host-pathogen interactions. RNF7 antibodies thus aid in unraveling its therapeutic potential as a biomarker or drug target, though its dual roles in pro-survival and stress-response pathways require careful contextual analysis.